# EDGAR Filing Document

**Accession Number:** 0001816590
**File Stem:** 0001140361-26-005810
**Filing Date:** 2026-2
**Character Count:** 9016
**Document Hash:** 38a03b3948a5c28ada78913a390a20a8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-26-005810.hdr.sgml**: 20260217

**ACCESSION NUMBER**: 0001140361-26-005810

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260217

**DATE AS OF CHANGE**: 20260217

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** COMPASS Pathways plc
- **CENTRAL INDEX KEY:** 0001816590
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92194
- **FILM NUMBER:** 26642866

**BUSINESS ADDRESS:**
- **STREET 1:** 3RD FLOOR, 1 ASHLEY ROAD
- **STREET 2:** ALTRINCHAM
- **CITY:** CHESIRE
- **STATE:** X0
- **ZIP:** WA14 2DT
- **BUSINESS PHONE:** 1-716-676-6461

**MAIL ADDRESS:**
- **STREET 1:** 3RD FLOOR, 1 ASHLEY ROAD
- **STREET 2:** ALTRINCHAM
- **CITY:** CHESIRE
- **STATE:** X0
- **ZIP:** WA14 2DT

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Compass Rx Ltd.
- **DATE OF NAME CHANGE:** 20200701
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AtaiBeckley Inc.
- **CENTRAL INDEX KEY:** 0002081043
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** C/O ATAI LIFE SCIENCES US, INC.
- **STREET 2:** C/O INDUSTRIOUS NYC, 250 WEST 34TH ST.
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10119
- **BUSINESS PHONE:** 1 929 207 2670

**MAIL ADDRESS:**
- **STREET 1:** C/O ATAI LIFE SCIENCES US, INC.
- **STREET 2:** C/O INDUSTRIOUS NYC, 250 WEST 34TH ST.
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10119

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** atai Life Sciences Luxembourg S.A.
- **DATE OF NAME CHANGE:** 20250811

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 6)**

**COMPASS Pathways plc**

*(Name of Issuer)*

**Ordinary Shares**

*(Title of Class of Securities)*

**20451W101**

*(CUSIP Number)*

**Ryan Barrett**<br>c/o atai Life Sciences US, Inc.<br>250 West 34th Street<br>New York NY 10119<br>1 929 207 2670

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**01/21/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **20451W101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**AtaiBeckley Inc.** | Name of reporting person<br>**AtaiBeckley Inc.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**4764710.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**4764710.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**4764710.00** | Aggregate amount beneficially owned by each reporting person<br>**4764710.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**4.96%** | Percent of class represented by amount in Row (11)<br>**4.96%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Ordinary Shares

**(b) Name of Issuer:**
COMPASS Pathways plc

**(c) Address of Issuer's Principal Executive Offices:**
33 Broadwick Street, London, X0, W1F 0DQ

This Amendment No. 6 to Schedule 13D amends and supplements the Schedule 13D originally filed with the United States Securities and Exchange Commission (the "SEC") on May 24, 2021 (as amended, the "Schedule 13D") relating to the ordinary shares, nominal value _0.008 per ordinary share (the "Ordinary Shares"), of COMPASS Pathways plc, a public limited company under the laws of England and Wales (the "Issuer"). Capitalized terms used herein without definition shall have the meaning set forth in the Schedule 13D.

CUSIP number 20451W101 has been assigned to the American Depositary Shares ("ADSs") of the Issuer, which are quoted on The Nasdaq Stock Market under the symbol "CMPS." Each ADS represents one Ordinary Share of the Issuer. No CUSIP number has been assigned to the Ordinary Shares of the Issuer.

Following certain strategic transactions, ATAI Life Sciences N.V. is now known as AtaiBeckley Inc., a Delaware corporation, and its principal executive offices are located at c/o atai Life Sciences US, Inc., c/o Industrious NYC, 250 West 34th Street, New York, New York 10119.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 of the Schedule 13D is amended and restated in its entirety by inserting the following information:

The information contained on the cover pages is incorporated by reference to this Item 5.

As of January 21, 2026, AtaiBeckley Inc. may be deemed to beneficially own 4,764,710 Ordinary Shares, representing approximately 4.96% of the 96,017,044 Ordinary Shares outstanding as of October 30, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed by the Issuer on November 4, 2025.

**(b)**
The information contained on the cover pages is incorporated by reference to this Item 5.

AtaiBeckley Inc. directly holds the securities reported herein.

**(c)**
During the 60 days prior to and including January 21, 2026, AtaiBeckley Inc. effected the following open market sales of ADSs representing Ordinary Shares:

11/24/2025: 20,000 shares for a weighted average price of $5.0865 per share. Price range: $5.00 to $5.21.

11/25/2025: 20,000 shares for a weighted average price of $5.1785 per share. Price range: $5.095 to $5.265

11/26/2025: 20,000 shares for a weighted average price of $5.1996 per share. Price range: $5.10 to $5.27

11/28/2025: 20,000 shares for a weighted average price of $5.4482 per share. Price range: $5.25 to $5.555

12/01/2025: 20,000 shares for a weighted average price of $5.2805 per share. Price range: $5.205 to $5.48

12/02/2025: 19,000 shares for a weighted average price of $5.1052 per share. Price range: $5.00 to $5.34

12/03/2025: 19,000 shares for a weighted average price of $5.0744 per share. Price range: $5.00 to $5.16

12/04/2025: 19,000 shares for a weighted average price of $5.3811 per share. Price range: $5.07 to $5.68

01/09/2026: 33,000 shares for a weighted average price of $7.3105 per share. Price range: $7.11 to $7.77

01/12/2026: 47,000 shares for a weighted average price of $7.0056 per share. Price range: $6.86 to $7.225

01/13/2026: 50,000 shares for a weighted average price of $7.1793 per share. Price range: $6.87 to $7.395

01/14/2026: 50,000 shares for a weighted average price of $7.4859 per share. Price range: $7.31 to $7.67

01/15/2026: 50,000 shares for a weighted average price of $7.3517 per share. Price range: $7.16 to $7.74

01/16/2026: 50,000 shares for a weighted average price of $7.3355 per share. Price range: $7.10 to $7.46

01/20/2026: 50,000 shares for a weighted average price of $7.2988 per share. Price range: $7.16 to $7.45

01/21/2026: 48,105 shares for a weighted average price of $7.0475 per share. Price range: $6.905 to $7.405

AtaiBeckley Inc. undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the full information regarding the number of shares sold at each separate price.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** AtaiBeckley Inc.

**Signature:** /s/ Anne Johnson

**Name/Title:** Anne Johnson, Chief Financial Officer

**Date:** 02/17/2026